Assessment of growth hormone status in acromegaly: what biochemical markers to measure and how? (Q34030633)

30 July 2017

1 reference

title

Assessment of growth hormone status in acromegaly: what biochemical markers to measure and how? (English)

1 reference

30 July 2017

author

Cecilia Camacho-Hübner

series ordinal

1

object named as

Camacho-Hübner C

1 reference

30 July 2017

publication date

1 April 2000

1 reference

Growth Hormone & I G F Research

30 July 2017

published in

1 reference

30 July 2017

volume

10 Suppl B

1 reference

30 July 2017

page(s)

S125-9

1 reference

Effects of recombinant human insulin-like growth factor I (IGF-I) therapy on the growth hormone-IGF system of a patient with a partial IGF-I gene deletion.

30 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2800%2980024-6

7 January 2021

Diagnosis of growth-hormone deficiency in adults

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2800%2980024-6

7 January 2021

Optimizing growth hormone replacement therapy by dose titration in hypopituitary adults.

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2800%2980024-6

7 January 2021

https://api.crossref.org/works/10.1016%2FS1096-6374%2800%2980024-6

1 reference

7 January 2021

Somatomedin-C Mediates Growth Hormone Negative Feedback by Effects on Both the Hypothalamus and the Pituitary

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2800%2980024-6

7 January 2021

The ratio between serum levels of insulin-like growth factor (IGF)-I and the IGF binding proteins (IGFBP-1, 2 and 3) decreases with age in healthy adults and is increased in acromegalic patients

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2800%2980024-6

7 January 2021

Insulin-like growth factor (IGF)-binding protein 5 forms an alternative ternary complex with IGFs and the acid-labile subunit

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2800%2980024-6

7 January 2021

How much insulin-like growth factor I (IGF-I) circulates? Impact of standardization on IGF-I assay accuracy

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2800%2980024-6

7 January 2021

Valid measurements of total IGF concentrations in biological fluids. Recommendations from the 3rd International Symposium on Insulin-like Growth Factors

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2800%2980024-6

7 January 2021

Contrasting effects of oral and transdermal routes of estrogen replacement therapy on 24-hour growth hormone (GH) secretion, insulin-like growth factor I, and GH-binding protein in postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2800%2980024-6

7 January 2021

Somatomedin response to testosterone stimulation in children with male pseudohermaphroditism, cryptorchidism, anorchia, or micropenis

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2800%2980024-6

7 January 2021

Hyperprolactinemia is associated with increased immunoreactive somatomedin C in hypopituitarism

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2800%2980024-6

7 January 2021

Critically ill patients have high basal growth hormone levels with attenuated oscillatory activity associated with low levels of insulin-like growth factor-I.

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2800%2980024-6

7 January 2021

[Validation of the Düsseldorfer screening tool: a trait-based approach to assess psychological distress of cancer patients]

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2800%2980024-6

7 January 2021

Evaluation of Acromegaly by Radioimmunoassay of Somatomedin-C

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2800%2980024-6

7 January 2021

Plasma insulin-like growth factor-I/somatomedin-C in acromegaly: correlation with the degree of growth hormone hypersecretion

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2800%2980024-6

7 January 2021

IGFBP‐3 is a poor parameter for assessment of clinical activity in acromegaly

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2800%2980024-6

7 January 2021

Alterations in serum levels of insulin-like growth factors and insulin-like growth-factor-binding proteins in patients with colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2800%2980024-6

7 January 2021

10.1016/S1096-6374(00)80024-6

Identifiers

DOI

1 reference

30 July 2017

1 reference